e-learning
resources
London 2016
Sunday, 04.09.2016
Role of genetics and exposures in COPD and asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Alpha-1 antitrypsin phenotype determination using sebia isoelectrofocusing on dried blood spot samples
Stefania Ottaviani (Tromello, Italy), Stefania Ottaviani, Valentina Barzon, Laura Divizia, Angelo Guido Corsico, Ilaria Ferrarotti
Source:
International Congress 2016 – Role of genetics and exposures in COPD and asthma
Session:
Role of genetics and exposures in COPD and asthma
Session type:
Thematic Poster
Number:
1204
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Stefania Ottaviani (Tromello, Italy), Stefania Ottaviani, Valentina Barzon, Laura Divizia, Angelo Guido Corsico, Ilaria Ferrarotti. Alpha-1 antitrypsin phenotype determination using sebia isoelectrofocusing on dried blood spot samples. Eur Respir J 2016; 48: Suppl. 60, 1204
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Late Breaking Abstract - Genetic diagnosis of alpha-1 antitrypsin deficiency using saliva samples
Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases
Year: 2020
Alpha 1-globulin fraction of serum protein electrophoresis for screening and early detection of alpha 1 antitrypsin deficiency
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018
Rapid DNA extraction from dried blood spots for the alpha-1 antitrypsin deficiency detection by real-time PCR
Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma
Year: 2012
Accurate and reliable determination of alpha1-antitrypsin levels in respiratory patients using dried blood spot specimens
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
A high purity alpha-1 antitrypsin (AAT) from human plasma, TAL6004
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009
Quantification of circulating alpha-1-antitrypsin polymers in dried blood spots
Source: Virtual Congress 2020 – Chronic lung diseases: novel methods, diagnostics and biomarkers
Year: 2020
Screening for a1-antitrypsin deficiency in the pneumologist’s office using a dried blood spots kit: promising first results.
Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases
Year: 2017
Routine serum protein electrophoresis and detection of alpha
1
-antitrypsin deficiency
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
Alpha 1 - antitrypsin deficiency: diagnosis and treatment
Source: Virtual Congress 2021 – Alpha 1 - antitrypsin deficiency: diagnosis and treatment
Year: 2021
Molecular diagnosis of Alpha-1 antitrypsin deficiency: a new method based on Luminex Technology
Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases
Year: 2017
Molecular characterization of novel PiS-like alleles identified in Spanish patients with Alpha-1 antitrypsin deficiency
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018
Diagnosing alpha-1 antitrypsin deficiency in Romania - first 1000 cases tested
Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement?
Year: 2020
Intra-epithelial polymerization, accumulation and secretion of alpha
1
antitrypsin (AAT) Z polymers in the lung of patients with alpha-1 antitrypsin deficiency (AATD)
Source: Annual Congress 2010 - Epithelial cell biology
Year: 2010
Alpha-1 antitrypsin (AAT) and alpha-2 macroglobulin (AMG) levels according to the stages and histological types in lung cancer
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008
Screening of alpha-1 antitrypsin deficiency in a blood donors cohort of the North-Italian area
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015
Alpha-1 antitrypsin: functional analysis of novel variants
Source: Research Seminar 2014 - Protein quality control in lung disease
Year: 2014
Regional deposition of
99m
Tc-labelled alpha-1 antitrypsin (AAT) in patients with alpha-1 antitrypsin deficiency and cystic fibrosis (CF) compared with healthy volunteers
Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects
Year: 2007
Pilot study for detection of alpha-1 antitrypsin deficiency in a targeted Argentinean population
Source: Eur Respir J 2005; 26: Suppl. 49, 59s
Year: 2005
Alpha-1 antitrypsin deficiency in COPD patients: Time to count it in!
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Plasma circulating miRNAs as diagnostic and prognostic biomarkers in alpha-1 antitrypsin deficiency.
Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept